PATRIZIO ARMENI

Associate Professor of Practice

SDA Bocconi School of Management

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Patrizio Armeni is an Associate Professor of Practice at SDA Bocconi School of Management in Italy. His research areas include health technology assessment, cost-effectiveness analysis, and value-based pricing in healthcare. He has contributed to several articles addressing topics such as digital twins in healthcare, early access programs for medicines, and the economic evaluation of medical technologies. His work aims to enhance evidence-based medicine and improve access to innovative health solutions.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

Czech Technical University in Prague

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

PATRIZIO ARMENI

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Digital Twins in Healthcare: Is It the Beginning of a New Era of Evidence-Based Medicine? A Critical Review

Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies

Reflections on the importance of cost of illness analysis in rare diseases: A proposal

A Value-based Revolution in Health Care: Perspectives, Challenges, and Emerging Approaches to Defining and Measuring the Value of Health Care Technologies

Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service

Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service

Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients

Cost–benefit Analysis in Health Care: The Case of Bariatric Surgery Compared With Diet

Implementation of Value-based Pricing for Medicines

Collaborators (5)

LORENZO DIAFERIA

ROSANNA TARRICONE

MARIANNA CAVAZZA

Claudio Jommi

Gleb Donin

Make your next move.